Clinical Features of Patients With Hematological Malignancies Treated at the Palliative Care Unit.

ABSTRACT:

Background

In Japan, the number of patients with aggressive hematological malignancies (PHMs) admitted at the palliative care unit (PCU) in their end-of-life (EOL) stage was fewer than that of patients with solid tumors due to several reasons. The assessment of patient characteristics and the methods of survival prediction among PHMs in the EOL stage are warranted.

Objectives

This study aimed to identify the current medical status and the method of survival prediction among PHMs treated at the PCU.

Setting/subjects/measurements

We retrospectively analyzed the clinical data of 25 PHMs treated at our PCU between January 2017 and December 2020. The association between survival time and the palliative prognostic score (PAP) and palliative prognostic index (PPI) was analyz

SUBMITTER: Yamane H 

PROVIDER: S-EPMC10541919 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature